Clinical trial

Predicting Recurrence in HR+/HER2- Early Breast Cancer

NCT07484763

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-04-01

PhaseN/A

Study timeline

Study start (estimated)2026-04-01Date precision: day

Registry last updated2026-03-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer, HR+/HER2- Early-Stageunresolved

Interventions

Sponsors & collaborators

Shengjing Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07484763 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.